Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02764437 · ClinicalTrials.gov registry record
AsthMatic Inflammation and Neurocircuitry Activation (MINA)
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 43
- Enrollment target
NCT02764437 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 43 participants.
The verdict
NCT02764437 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The investigators have identified areas of the brain that are activated in response to disease-related emotional information, following whole lung allergen challenge in asthma. They propose that activity in these central nervous system locations, as measured by fMRI, is associated with the intensity of allergic inflammation, provoked by segmental bronchial challenge, in the absence of significant airflow obstruction. The investigators predict that this relationship will be mediated by changes in expression of genes in the IL-1β/IL-17 pathway.
Interventions
- BIOLOGICAL Whole lung antigen challenge, segmental allergen challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2016-07-28 |
| Est. Completion | 2020-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02764437
The ClinicalTrials.gov registry entry for NCT02764437 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole lung antigen challenge, segmental allergen challenge is the first listed.
NCT02764437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02764437 about?
NCT02764437 is a clinical study titled "AsthMatic Inflammation and Neurocircuitry Activation (MINA)". The investigators have identified areas of the brain that are activated in response to disease-related emotional information, following whole lung allergen challenge in asthma. They propose that activity in these central nervous system locations, as measured by fMRI, is associated with the intensity...
What is the current status of trial NCT02764437?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2016-07-28. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT02764437?
The interventions under investigation include: Whole lung antigen challenge, segmental allergen challenge (BIOLOGICAL).
Who is sponsoring clinical trial NCT02764437?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.